Compounds and compositions for treating conditions associated with NLRP activity
In one aspect, compounds of Formulae (I) and (II), or pharmaceutically acceptable salts thereof, are featured: Formulae (I) and (II), wherein the variables shown in Formulae (I) and (II) can be as defined anywhere herein.
1. A compound selected from the group consisting of compounds in the Table below:
Com-
pound
Structure
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
131
135
136
137
138
142
143
144
145
146
147
148
149
151
153
154
155
157
158
159
160
161
163
164
166
167
168
169
170
and
171
or pharmaceutically acceptable salts thereof.
2. A pharmaceutical composition comprising a compound or salt as claimed in claim 1 and one or more pharmaceutically acceptable excipients.